Upcoming Events
Search Result For "Antibodydrugconjugate".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and m...
The 13th World ADC London returns in 2023 as Europe's longest standing and definitive antibody-drug conjugate event - and it's back bigger and bett...
As the proportion of clinically site-specific ADCs increases, the abundance of novel conjugation technologies diversifies, and the linker chemistry...
The ADC renaissance has continued to dominate the oncology field throughout 2023, with the long-awaited approval of ImmunoGen's ELAHERE - the 9th A...
Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable ...
As ADCs as a modality see continued clinical progress, drug developers are becoming more creative with their drug design and new analytical technol...